On September 28, 2022, Mark C. Wiggins notified TRACON Pharmaceuticals, Inc. that he was resigning as the Company's Chief Business Officer, effective September 30, 2022, to pursue other professional opportunities. Mr. Wiggins' resignation is not a result of any disagreement with the Company, and he has agreed to serve as a consultant to the Company following his resignation.